Epidemiologic evidence shows that obesity is associated with a greater risk of aggressive prostate cancer (PCa) and PCa-specific mortality and this is observed mainly in men with the TMPRSS2-ERG gene fusion. This evidence concerns the gene TMPRSS2 and obesity due to melanocortin 4 receptor deficiency.